Ensure COPFS budget increase isn’t simply ‘a flash in the pan’, FDA urges Scottish Government
The FDA’s Procurator Fiscal Society (PFS) section has given both written and oral evidence to the Justice Committee during its pre-budget scrutiny of the Scottish Government’s draft budget.
FDA President Fiona Eadie, who spoke to the Committee on behalf of PFS in early October, said: “While we welcome the in-year budget increase, the Cabinet Secretary for Finance must ensure this comes as part of a sustained, long-term commitment to adequately resource the COPFS and isn’t simply a flash in the pan.”
She explained: “Years of budget restrictions mean that the £3.6 million increase still represents a real-terms cut of 23.3% compared to 2010 spending levels and bringing in additional prosecutors will not solve the problem overnight.
“We know that a significant number of our members have left the COPFS to move to the Scottish Government, where they will be earning up to £10,000 more than they did as Procurators Fiscal.”
Eadie added: “It can’t be right that those who deal with victims of child sexual abuse and the prosecution of some of the most violent offenders in Scotland are valued less than their Scottish Government counterparts.
“Any long-term strategy must address these discrepancies to ensure the COPFS can recruit and retain the dedicated staff needed to deliver justice for the people of Scotland.”
Related News
-
Under significant pressure: Interview with Director of Public Prosecutions
Tom Nathan speaks to Crown Prosecution Service Director of Public Prosecutions Stephen Parkinson about CPS’s handling of riots, the importance of impartiality and his plan to help reduce unmanageable prosecutor caseloads.
-
Changing the culture
HM Chief Inspector Sir Martyn Oliver sat down for an ‘in conversation’ event with FDA General Secretary Dave Penman, discussing the pace of change in Ofsted, challenging perceptions and tackling the long hours culture in Education.
-
Hybrid working: Led by evidence, not headlines
Tom Nathan shares the findings and recommendations of the FDA’s recent report on ‘The future of office working in the civil service’.